Exact Mass: 299.9898

Exact Mass Matches: 299.9898

Found 160 metabolites which its exact mass value is equals to given mass value 299.9898, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Tolclofos-methyl

C9H11Cl2O3PS (299.9544)

CONFIDENCE standard compound; INTERNAL_ID 461; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9291; ORIGINAL_PRECURSOR_SCAN_NO 9287 CONFIDENCE standard compound; INTERNAL_ID 461; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9271; ORIGINAL_PRECURSOR_SCAN_NO 9267 CONFIDENCE standard compound; INTERNAL_ID 461; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9337; ORIGINAL_PRECURSOR_SCAN_NO 9333 CONFIDENCE standard compound; INTERNAL_ID 461; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9322; ORIGINAL_PRECURSOR_SCAN_NO 9318 CONFIDENCE standard compound; INTERNAL_ID 461; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9241; ORIGINAL_PRECURSOR_SCAN_NO 9237

Cinnavalininate

2-amino-3-oxo-3H-phenoxazine-1,9-dicarboxylic acid

C14H8N2O6 (300.0382)

Cinnavalininate is an intermediate in the tryptophan metabolic pathway [Kegg: C05640]. It is generated from 3-hydroxyanthranilate via the enzyme catalase (EC:1.11.1.6). [HMDB] Cinnavalininate is an intermediate in the tryptophan metabolic pathway [Kegg: C05640]. It is generated from 3-hydroxyanthranilate via the enzyme catalase (EC:1.11.1.6). Cinnabarinic acid is a specific orthosteric agonist of mGlu4 by interacting with residues of the glutamate binding pocket of mGlu4, has no activity at other mGlu receptors. Cinnabarinic acid is an endogenous metabolite of the kynurenine pathway of tryptophan. Cinnabarinic acid induces cell apoptosis[1].

Pseudopurpurin

C15H8O7 (300.027)

Demethylwedelolactone

C15H8O7 (300.027)

Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2]. Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2].

Perfluorobutanesulfonic acid

1,1,2,2,3,3,4,4,4-Nonafluoro-1-butanesulphonic acid

C4HF9O3S (299.9503)

Isodemethylwedelolacton

2,4,8,9-Tetrahydroxy-6H-benzofuro[3,2-c][1]benzopyran-6-one

C15H8O7 (300.027)

UXN2KXV8BB

6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 1,3,8,9-tetrahydroxy-

C15H8O7 (300.027)

Demethylwedelolactone is a member of coumestans. Demethylwedelolactone is a natural product found in Sphagneticola calendulacea, Eclipta alba, and other organisms with data available. Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2]. Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2].

Emodic acid

2-Anthracenecarboxylic acid, 9,10-dihydro-4,5,7-trihydroxy-9,10-dioxo-

C15H8O7 (300.027)

Emodicacid is a member of anthracenes.

Aplysiapyranoid C

C10H15BrCl2O (299.9683)

Norwedelolactone

5,7,11,12-Tetrahydroxycoumestan

C15H8O7 (300.027)

Isodemethylwedelolactone

C15H8O7 (300.027)

perfluorobutanesulfonic acid

Perfluorobutane sulfonic acid (PFBuS)

C4HF9O3S (299.9503)

CONFIDENCE standard compound; INTERNAL_ID 5955 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3675

STA-0DC (TENTATIVE)

C12H12O7S (300.0304)

TENTATIVELY IDENTIFIED SPECTRUM ONLY!!!!!!!!!; BASE PEAK ARISES FROM CO-ELUTING COMPOUND!!!!!; Extracted (without noise removal) from ZUE_N: mz299_02_rt8_95_HCD60_STA-0DC; CONFIDENCE Tentative identification: best match only (Level 3)

longamide C

C11H13BrN2O3 (300.0109)

SCHEMBL17867355

C10H20S5 (300.0169)

4-Phenyl-5-benzyl-dithiol-(1,2)-thion-(3)|5-Benzyl-4-phenyl-[1,2]dithiol-3-thion|5-benzyl-4-phenyl-[1,2]dithiol-3-thione|5-benzyl-4-phenyl-[1,2]dithiole-3-thione

C16H12S3 (300.0101)

Sodium phosphonatoformate hexahydrate

Phosphonoformic acid trisodium salt hexahydrate

CH12Na3O11P (299.981)

C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent

(4-Chlorophenyl)(4-(trifluoromethoxy)phenyl)methanone

C14H8ClF3O2 (300.0165)

1-chloro-4-[(4-chlorophenyl)sulfanylmethylsulfanyl]benzene

C13H10Cl2S2 (299.9601)

3-bromo-4-(2,2-dimethylpropanoyloxy)benzoic acid

C12H13BrO4 (299.9997)

3-bromo-4-(oxan-4-yloxy)benzoic acid

C12H13BrO4 (299.9997)

5-(4-methylphenyl)sulfonyl-2-methylsulfanyl-1,3-thiazol-4-amine

C11H12N2O2S3 (300.0061)

3,6-Di(2-thienyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-1,4-dione

C14H8N2O2S2 (300.0027)

4-(4-bromophenyl)-2H-phthalazin-1-one

C14H9BrN2O (299.9898)

2,2,3,3,4,4,5,5,6,6,6-Undecafluoro-1-hexanol

C6H3F11O (300.0008)

1-(2-Bromo-4-nitrophenyl)piperidin-4-ol

C11H13BrN2O3 (300.0109)

1-((4-BROMOPHENYL)SULFONYL)-2-METHYL-1H-IMIDAZOLE

C10H9BrN2O2S (299.9568)

3,5-Dinitrobenzil

C14H8N2O6 (300.0382)

Methyl 2-chloro-3-[2-chloro-4-(trifluoromethyl)phenyl]propanoate

C11H9Cl2F3O2 (299.9932)

2-chloro-N-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide

C13H8ClF3N2O (300.0277)

5-exo,6-endo,7-exo,8-endo-5,6,7,8-tetra(chloromethyl)-bicyclo[2.2.2]oct-2-ene

C12H16Cl4 (300.0006)

6-bromoflavone

C15H9BrO2 (299.9786)

Glycine, N-(carboxymethyl)-N-2-(carboxymethyl)aminoethyl-, trisodium salt

C8H11N2Na3O6 (300.031)

2-phenyl-3-sulfanylidene-4,6,7,8-tetrahydrocyclopenta[2,3]thieno[2,4-b]pyrimidin-1-one

C15H12N2OS2 (300.0391)

pentamethylcyclopentasiloxane

C5H20O5Si5 (300.0157)

hexafluoroisopropyl trifluoromethanesulfonate

C4HF9O3S (299.9503)

2,2,3,3,4,4,5,5-Octafluoropentyl methacrylate

C9H8F8O2 (300.0397)

3-bromo-N,N-diethyl-5-nitrobenzamide

C11H13BrN2O3 (300.0109)

2-(2-imino-1,3-thiazolidin-3-yl)-1-phenylethanone,hydrobromide

C11H13BrN2OS (299.9932)

2-NITRO-1-(2-PYRIDYLTHIO)-4-(TRIFLUOROMETHYL)BENZENE

C12H7F3N2O2S (300.018)

3-(2-Bromophenyl)-5-phenyl-1,2,4-oxadiazole

C14H9BrN2O (299.9898)

nifuroquine

C14H8N2O6 (300.0382)

Bromindione

C15H9BrO2 (299.9786)

C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent

7-chloro-2,4-bis(trifluoromethyl)-1,8-naphthyridine

C10H3ClF6N2 (299.9889)

2-(4-bromophenyl)-3-hydroxyinden-1-one

C15H9BrO2 (299.9786)

TRIMETHYLSTANNYLDIMETHYLPHENYLSILAN

C11H20SiSn (300.0356)

Perfluoro(4-methylpent-2-ene)

C6F12 (299.9808)

1-PYRENESULFONYL CHLORIDE

C16H9ClO2S (300.0012)

sodium,4-[2-(4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]benzenesulfonate

C12H9N2NaO4S (300.0181)

chlorbenside-sulfone

C13H10Cl2O2S (299.9779)

7-bromo-2-methyl-1-(pyridin-3-ylmethyl)indole

C15H13BrN2 (300.0262)

mercurous nitrate, dihydrate

H4HgNO5 (299.9796)

3-bromo-4-hexoxybenzoic acid

C13H17BrO3 (300.0361)

Sulfatrozole

C10H12N4O3S2 (300.0351)

2-(Boc-amino)-5-bromoisonicotinaldehyde

C11H13BrN2O3 (300.0109)

6-Bromo-3-phenyl-4(3H)-quinazolinone

C14H9BrN2O (299.9898)

1,1,1,2,2,2-hexanitroethane

C2N6O12 (299.9574)

4,6-Dichloro-2,5-diphenylpyrimidine

C16H10Cl2N2 (300.0221)

Nonafluoro(trifluoromethyl)cyclopentane

C6F12 (299.9808)

perfluorocyclohexane

C6F12 (299.9808)

((5-Thiazolyl)methyl)-(4-nitrophenyl)carbonate hydrochloride

C11H9ClN2O4S (299.9972)

diethyl 2-bromobenzene-1,4-dicarboxylate

C12H13BrO4 (299.9997)

2-Bromo-4-[3-(pyridin-2-yl)-1H-pyrazol-4-yl]pyridine

C13H9BrN4 (300.0011)

(6-bromo-1H-pyrrolo[2,3-b]pyridin-1-yl)(phenyl)methanone

C14H9BrN2O (299.9898)

methyl 1-(3,4-dichlorophenyl)-4-oxocyclohexane-1-carboxylate

C14H14Cl2O3 (300.032)

2-Sulfanilamido-5-nitrothiazole

C9H8N4O4S2 (299.9987)

isobromindione

C15H9BrO2 (299.9786)

M - Musculo-skeletal system > M04 - Antigout preparations > M04A - Antigout preparations > M04AB - Preparations increasing uric acid excretion C26170 - Protective Agent > C921 - Uricosuric Agent

Methanone, (5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl-

C14H9BrN2O (299.9898)

2-BENZO[1,3]DIOXOL-5-YL-6-CHLORO-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE

C15H9ClN2O3 (300.0302)

10-Bromoanthracene-9-boronic acid

C14H10BBrO2 (299.9957)

1-azido-4-[(4-azidophenyl)disulfanyl]benzene

C12H8N6S2 (300.0252)

2-(2-bromophenyl)-5-phenyl-1,3,4-oxadiazole

C14H9BrN2O (299.9898)

4,7-dithien-2-yl-2,1,3-benzothiadiazole

C14H8N2S3 (299.985)

N-(2-BROMO-6-NITROPHENYL)-N-ISOPROPYLACETAMIDE

C11H13BrN2O3 (300.0109)

3-(1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY)PYRIDIN-2-AMINE

C13H11Cl2FN2O (300.0232)

4′-Bromoflavone

C15H9BrO2 (299.9786)

S-Acetylthioglycolic acidpentafluorophenyl ester

C10H5F5O3S (299.988)

4-Iodo-1-(phenylMethoxy)-1H-pyrazole

C10H9IN2O (299.976)

2-(2-bromophenyl)indene-1,3-dione

C15H9BrO2 (299.9786)

(2-chlorophenyl)-(3,5-dichloro-2-hydroxyphenyl)methanone

C13H7Cl3O2 (299.9512)

(5-BROMO-1,3-PHENYLENE)BIS(TRIMETHYLSILANE)

C12H21BrSi2 (300.0365)

10-Bromoanthracene-9-carboxylic acid

C15H9BrO2 (299.9786)

perfluorodimethylcyclobutane

C6F12 (299.9808)

1H-Indene-1,3(2H)-dione,2-bromo-2-phenyl-

C15H9BrO2 (299.9786)

4-HYDROXY-6-OXO-1-(3-(TRIFLUOROMETHYL)PHENYL)-1,6-DIHYDROPYRIDAZINE-3-CARBOXYLIC ACID

C12H7F3N2O4 (300.0358)

1,1,4-Triacetoxy-2,2-dichlorobutane

C10H14Cl2O6 (300.0167)

(R)-3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine

C13H11Cl2FN2O (300.0232)

1-(4-Iodo-5-methyl-1H-pyrrolo[2,3-b]pyridin-1-yl)ethanone

C10H9IN2O (299.976)

Hexyl 5-bromo-2-hydroxybenzoate

C13H17BrO3 (300.0361)

oxolan-2-ylmethyl 5-bromo-2-hydroxybenzoate

C12H13BrO4 (299.9997)

Ethyl 3-bromo-4-butoxybenzoate

C13H17BrO3 (300.0361)

1,1,2,2-TETRAFLUORO-2-(1,1,2,2-TETRAFLUOROETHOXY)ETHANESULPHONYL FLUORIDE

C4HF9O3S (299.9503)

A-205804

4-(p-Tolylthio)thieno[2,3-c]pyridine-2-carboxamide

C15H12N2OS2 (300.0391)

Disodium 4-methyl-2-oxo-2H-chromen-7-yl phosphate

C10H7Na2O6P (299.9776)

2-iodo-4-(1,2,4-triazol-1-ylmethyl)aniline

C9H9IN4 (299.9872)

4-phenyl-1-(trideuteriomethyl)pyridin-1-ium,iodide

C12H9D3IN (300.0203)

1-[4-(5-bromopentoxy)-2-hydroxyphenyl]ethanone

C13H17BrO3 (300.0361)

2-[3-chloro-4-(trifluoromethyl)phenyl]benzoic acid

C14H8ClF3O2 (300.0165)

2-bromomethylanthraquinone

C15H9BrO2 (299.9786)

2-(4-bromo-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

C12H15BBrFO2 (300.0332)

4-CHLORO-3-(TRIFLUOROMETHYL)-[1,1-BIPHENYL]-3-CARBOXYLIC ACID

C14H8ClF3O2 (300.0165)

4-chloro-6-(4-chlorophenyl)-2-phenylpyrimidine

C16H10Cl2N2 (300.0221)

4-(biphenyl-4-yl)-2,6-dichloropyrimidine

C16H10Cl2N2 (300.0221)

1-((2-Bromophenyl)sulfonyl)-4-methyl-1H-imidazole

C10H9BrN2O2S (299.9568)

IRON PICOLINATE

C12H8FeN2O4 (299.9833)

2-Bromomethyl-4-fluorophenylboronic acid neopentyl glycol ester

C12H15BBrFO2 (300.0332)

Hexafluoropropylene dimer

C6F12 (299.9808)

5-Bromo-2-fluorophenylboronic acid pinacol ester

C12H15BBrFO2 (300.0332)

methyl (2Z,4Z)-5-chloro-2-(chloromethyl)-5-(4-methoxyphenyl)penta-2,4-dienoate

C14H14Cl2O3 (300.032)

4-(2,3-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-6-METHYL-2-OXO-5-PYRIMIDINECARBOXYLIC

C12H10Cl2N2O3 (300.0068)

2-(2-NITROPHENYLTHIO)ISOINDOLINE-1,3-DIONE

C14H8N2O4S (300.0205)

(4-IODOPHENYLETHYNYL)TRIMETHYLSILANE

C11H13ISi (299.9831)

9-Phenanthrenecarboxylicacid, 6-bromo-

C15H9BrO2 (299.9786)

Perfluoro-2-methyl-2-pentene

C6F12 (299.9808)

1,3,4-Oxadiazole,2-(4-bromophenyl)-5-phenyl-

C14H9BrN2O (299.9898)

2-(1,3,4-Oxadiazol-2-yl)phenyl 4-chlorobenzenecarboxylate

C15H9ClN2O3 (300.0302)

2-chloro-N-[3-[(2-chlorophenyl)methyl]-2-thiazolylidene]acetamide

C12H10Cl2N2OS (299.9891)

6-Hydroxy-11-methyl-13-(trifluoromethyl)-8-thia-3,10-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5,10,12-pentaen-4-one

C12H7F3N2O2S (300.018)

5,6-Bis[(2-hydroxyethyl)sulfanyl]benzimidazole-4,7-quinone

C11H12N2O4S2 (300.0238)

N-acetyl-D-galactosamine 6-O-sulfate

C8H14NO9S- (300.0389)

2-Amino-6-chloro-4-(3-sulfonatoanilino)-1,3,5-triazine

C9H7ClN5O3S- (299.9958)

N-acetyl-D-glucosamine 6-sulfate(1-)

C8H14NO9S- (300.0389)

N-acetyl-beta-D-galactosamine 4-O-sulfate

C8H14NO9S- (300.0389)

alpha-N-acetyl-D-glucosamine 3-sulfate

C8H14NO9S- (300.0389)

N-acetyl-beta-D-galactosamine 6-sulfate(1-)

C8H14NO9S- (300.0389)

Olsalazine(2-)

C14H8N2O6-2 (300.0382)

3-(3,4-dichlorophenyl)-N-(4,5-dihydro-1,3-thiazol-2-yl)acrylamide

C12H10Cl2N2OS (299.9891)

4-[5-(2-Chlorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid

C15H9ClN2O3 (300.0302)

1-(4-Bromophenyl)-3-(3-methylbutyl)thiourea

C12H17BrN2S (300.0296)

6-Oxo-1,6-dihydrodibenzo[cd,g]indazole-3-sulfonic acid

C14H8N2O4S (300.0205)

An arenesulfonic acid that is 1,6-dihydrodibenzo[cd,g]indazole-3-sulfonic acid substituted by an oxo group at position 6.

5-[(6-Hydroxy-4-oxo-1-benzopyran-3-yl)methylidene]-1,3-diazinane-2,4,6-trione

C14H8N2O6 (300.0382)

2-[(2,2-dichloro-3,3-dimethylcyclopropyl)methylthio]-1H-benzimidazole

C13H14Cl2N2S (300.0255)

4-(5-(3-Chlorophenyl)-1,2,4-oxadiazol-3-yl)benzoic acid

C15H9ClN2O3 (300.0302)

N3-(4-chlorophenyl)-4-(trifluoromethyl)nicotinamide

C13H8ClF3N2O (300.0277)

(3-Bromo-4-hydroxy-5-nitrophenyl)acetyl azide

C8H5BrN4O4 (299.9494)

5-(Methylsulfanyl)-2-(thiophen-2-yl)-3-(trifluoromethyl)pyridine-4-carbonitrile

C12H7F3N2S2 (300.0003)

Cinnabarinic acid

C14H8N2O6 (300.0382)

Cinnabarinic acid is a specific orthosteric agonist of mGlu4 by interacting with residues of the glutamate binding pocket of mGlu4, has no activity at other mGlu receptors. Cinnabarinic acid is an endogenous metabolite of the kynurenine pathway of tryptophan. Cinnabarinic acid induces cell apoptosis[1].